特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

欧州における泌尿器用治療機器の処置数

European Procedure Numbers for Urological Devices 2016 - MedPro

発行 iData Research Inc. 商品コード 373306
出版日 ページ情報 英文 97 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

欧州における泌尿器用治療機器の処置数 European Procedure Numbers for Urological Devices 2016 - MedPro
出版日: 2016年09月01日 ページ情報: 英文 97 Pages
概要

当レポートでは、欧州市場における各泌尿器用治療機器の処置数に関する調査結果をまとめています。

エグゼクティブサマリー

欧州の泌尿器用治療機器市場の概要

競合分析

市場動向

市場の発展

対象市場

調査対象処置

レポートの主なアップデート内容

バージョン履歴

調査手法

  • 調査範囲
  • IDATAの9段階の分析手法

疾患の概要

  • 基本構造
    • ヒトの泌尿器系
  • 泌尿器の病理学と疾患
    • 前立腺肥大症 (BPH)
    • 尿失禁
    • 尿路感染症 (UTI)
    • 腎臓結石
    • 膀胱脱
    • 過活動膀胱
    • 前立腺炎
    • 勃起不全 (ED)
  • 患者統計
    • 前立腺肥大症
    • 尿失禁
    • UTI
    • 腎臓結石
    • 勃起不全
    • 過活動膀胱
    • 前立腺炎

各国のプロファイル

  • イントロダクション
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ベネルクス
  • スカンジナビア
  • オーストリア
  • スイス
  • ポルトガル

処置数

  • 処置の概要
  • 前立腺癌の治療処置
  • 前立腺肥大症のインターベンション治療
  • 結石管理
  • 腎瘻造設
  • 尿失禁P
  • 勃起不全管理

略語集

付録:企業のプレスリリース

目次
Product Code: iDATA_EUUR16_MP

The European urology market includes the segments for TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices. As a whole the urological device market is very well established. This limits potential for substantial growth. Although companies continue to provide novel adaptations to their products, the general trend within the market is a slightly declining ASP. However, some segments are an exception to this - lasers (for both BPH and stone management) have recently seen some exciting developments.

Segments Covered in this Procedure Volume Research

This market study focuses specifically on the volume of procedures. It includes analysis of procedures.

This data outlines the exact growth rates for procedures. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports, which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore.

Where Do We Get Our Procedure Data?

Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic soft tissue procedure volumes that influence and coincide with our overall market sizing.

Questions This Report will Help You Answer:

What is affecting the volume of procedures?

How many procedures were done in 2016?

How many procedures were done historically?

How many procedures can we expect in 2023 and what is the growth trend?

TABLE OF CONTENTS I

LIST OF FIGURES XIII

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 6

MARKET DEVELOPMENTS 8

MARKETS INCLUDED 9

PROCEDURES INCLUDED 11

KEY REPORT UPDATES 12

VERSION HISTORY 12

RESEARCH METHODOLOGY 13

  • 1.1 RESEARCH SCOPE 13
  • 1.2 IDATA'S 9-STEP METHODOLOGY 13
    • Step 1: Project Initiation & Team Selection 13
    • Step 2: Prepare Data Systems and Perform Secondary Research 15
    • Step 3: Preparation for Interviews & Questionnaire Design 16
    • Step 4: Performing Primary Research 17
    • Step 5: Research Analysis: Establishing Baseline Estimates 19
    • Step 6: Market Forecast and Analysis 20
    • Step 7: Identify Strategic Opportunities 22
    • Step 8: Final Review and Market Release 23
    • Step 9: Customer Feedback and Market Monitoring 24

DISEASE OVERVIEW 25

  • 2.1 BASIC ANATOMY 25
    • 2.1.1 Human Urinary System 25
  • 2.2 URINARY PATHOLOGY AND DISORDERS 26
    • 2.2.1 Benign Prostate Hyperplasia (BPH) 26
    • 2.2.2 Urinary Incontinence 27
    • 2.2.3 Urinary Tract Infections (UTI) 27
    • 2.2.4 Kidney Stones 28
    • 2.2.5 Bladder Prolapse 29
    • 2.2.6 Overactive Bladder 29
    • 2.2.7 Prostatitis 30
    • 2.2.8 Erectile Dysfunction (ED) 30
    • 2.2.9 Cancer 31
      • 2.2.9.1.1 Prostate Cancer 31
      • 2.2.9.1.2 Bladder Cancer 32
  • 2.3 PATIENT DEMOGRAPHICS 34
    • 2.3.1 Benign Prostatic Hyperplasia 34
    • 2.3.2 Urinary Incontinence 34
    • 2.3.3 UTI 35
    • 2.3.4 Kidney Stones 35
    • 2.3.5 Erectile Dysfunction 36
    • 2.3.6 Overactive Bladder 37
    • 2.3.7 Prostatitis 37
    • 2.3.8 Cancer 38
      • 2.3.8.1 Prostate Cancer 38
      • 2.3.8.2 Bladder Cancer 38

COUNTRY PROFILES 40

  • 3.1 INTRODUCTION 40
      • 3.1.1.1 Population 40
      • 3.1.1.2 Median Age 40
      • 3.1.1.3 GDP Per Capita 40
      • 3.1.1.4 Price Index 40
  • 3.2 GERMANY 42
  • 3.3 FRANCE 43
  • 3.4 UNITED KINGDOM 44
  • 3.5 ITALY 45
  • 3.6 SPAIN 46
  • 3.7 BENELUX 47
  • 3.8 SCANDINAVIA 48
  • 3.9 AUSTRIA 49
  • 3.10 SWITZERLAND 50
  • 3.11 PORTUGAL 51

PROCEDURE NUMBERS 52

  • 4.1 PROCEDURE OVERVIEW 52
  • 4.2 PROSTATE CANCER TREATMENT PROCEDURES 55
  • 4.3 INTERVENTIONAL BPH PROCEDURES 68
  • 4.4 STONE MANAGEMENT PROCEDURES 75
  • 4.5 NEPHROSTOMY PROCEDURES 83
  • 4.6 URINARY INCONTINENCE PROCEDURES 86
  • 4.7 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 92

ABBREVIATIONS 95

APPENDIX II: COMPANY PRESS RELEASES 97

LIST OF CHARTS

  • Chart 1 1: Total Urological Device Market, Europe, 2012 - 2022 2
  • Chart 1 2: Total Urological Device Market Overview, Europe, 2015 & 2022 2
  • Chart 3 1: Country Profile, Germany, 2015 42
  • Chart 3 2: Country Profile, France, 2015 43
  • Chart 3 3: Country Profile, United Kingdom, 2015 44
  • Chart 3 4: Country Profile, Italy, 2015 45
  • Chart 3 5: Country Profile, Spain, 2015 46
  • Chart 3 6: Country Profile, Benelux, 2015 47
  • Chart 3 7: Country Profile, Scandinavia, 2015 48
  • Chart 3 8: Country Profile, Austria, 2015 49
  • Chart 3 9: Country Profile, Switzerland, 2015 50
  • Chart 3 10: Country Profile, Portugal, 2015 51
  • Chart 4 1: Prostate Cancer Treatment Procedures by Type, Europe, 2012 - 2022 67
  • Chart 4 2: Interventional BPH Procedures by Type, Europe, 2012 - 2022 74
  • Chart 4 3: Stone Management Procedures by Type, Europe, 2012 - 2022 82
  • Chart 4 4: Nephrostomy Procedures, Europe, 2012 - 2022 85
  • Chart 4 5: Urinary Incontinence Procedures by Type, Europe, 2012 - 2022 91
  • Chart 4 6: Erectile Dysfunction Management Procedures by Type, Europe, 2013 - 2022 94

LIST OF FIGURES

  • Figure 1 1: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2) 3
  • Figure 1 2: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2) 4
  • Figure 1 3: Companies Mentioned in Report 5
  • Figure 1 4: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2) 6
  • Figure 1 5: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2) 7
  • Figure 1 6: Recent Events in Urological Device Market, Europe, 2012 - 2016 8
  • Figure 1 7: Urological Device Markets Covered, Europe, 2015, (Part 1 of 2) 9
  • Figure 1 8: Urological Device Markets Covered, Europe, 2015, (Part 2 of 2) 10
  • Figure 1 9: Urological Procedures Covered, Europe, 2015 11
  • Figure 1 10: Key Report Updates 12
  • Figure 1 11: Version History 12
  • Figure 4 1: Urological Procedures by Type, Europe, 2012 - 2022 53
  • Figure 4 2: Urological Procedures by Type, Europe, 2012 - 2022 54
  • Figure 4 3: Total Prostate Cancer Procedures by Type, Europe, 2012 - 2022 57
  • Figure 4 4: Total Prostate Cancer Procedures by Country, Europe, 2012 - 2022 58
  • Figure 4 5: Open and Laparoscopic Prostatectomy Procedures by Country, Europe, 2012 - 2022 59
  • Figure 4 6: Robotic Prostatectomy Procedures by Country, Europe, 2012 - 2022 60
  • Figure 4 7: Watchful Waiting Procedures by Country, Europe, 2012 - 2022 61
  • Figure 4 8: HIFU Procedures by Country, Europe, 2012 - 2022 62
  • Figure 4 9: Brachytherapy Procedures by Country, Europe, 2012 - 2022 63
  • Figure 4 10: HDR Procedures by Country, Europe, 2012 - 2022 64
  • Figure 4 11: External Radiation Therapy (Primary) Procedures by Country, Europe, 2012 - 2022 65
  • Figure 4 12: External Radiation Therapy (Secondary) Procedures by Country, Europe, 2012 - 2022 66
  • Figure 4 13: Interventional BPH Procedures by Type, Europe, 2012 - 2022 70
  • Figure 4 14: Interventional BPH Procedures by Country, Europe, 2012 - 2022 71
  • Figure 4 15: TURP Procedures by Country, Europe, 2012 - 2022 72
  • Figure 4 16: Laser BPH Procedures by Country, Europe, 2012 - 2022 73
  • Figure 4 17: Stone Management Procedures by Type, Europe, 2012 - 2022 76
  • Figure 4 18: Stone Management Procedures by Country, Europe, 2012 - 2022 77
  • Figure 4 19: ESWL Procedures by Country, Europe, 2012 - 2022 78
  • Figure 4 20: Ureteroscopy Procedures by Country, Europe, 2012 - 2022 79
  • Figure 4 21: PCNL Procedures by Country, Europe, 2012 - 2022 80
  • Figure 4 22: Ureteral Stent Placement Procedures by Country, Europe, 2012 - 2022 81
  • Figure 4 23: Nephrostomy Procedures by Country, Europe, 2012 - 2022 84
  • Figure 4 24: Urinary Incontinence Procedures by Type, Europe, 2012 - 2022 87
  • Figure 4 25: Urinary Incontinence Procedures by Country, Europe, 2012 - 2022 88
  • Figure 4 26: Male Urinary Incontinence Procedures by Country, Europe, 2012 - 2022 89
  • Figure 4 27: Female Urinary Incontinence Procedures by Country, Europe, 2012 - 2022 90
  • Figure 4 28: Erectile Dysfunction Management Procedures by Type, Europe, 2012 - 2022 92
  • Figure 4 29: Erectile Dysfunction Management Procedures by Country, Europe, 2012 - 2022 93
  • Figure 6 1: Press Release Summary 98